no. 553142; BD Pharmingen, Becton Dickinson, San Jose, CA, USA). Staining was carried out in 5H buffer to detect H-2Db (expressed on NOD, C57BL/6J and CByB6F1/J lymphocytes) and H-2Kb– (C57BL/6J and CByB6F1/J mice) using the following antibodies: α-H-2Db-phycoerythrin

(PE) (clone KH95, cat. no. 111507; BioLegend, Inc., San Diego, CA, USA), α-H-2Kb-AlexaFluor 647 (cat. no. 116511, clone AF6-88.5; BioLegend), α-CD4-Horizon (cat. no. 48-0042-82, clone RM4-5; eBioscience, Inc., San Diego, CA, USA), α-CD8α-biotin (cat. no. 13-0081-82, clone 53-6.7; eBioscience) in combination with streptavidin–AlexaFluor 488 (cat. no. S32354; Molecular Probes, Invitrogen). 7-Aminoactinomycin D (7AAD) (cat. no. 559925; BD Pharmingen, Becton Dickinson) was selleck chemicals used for live/dead cell discrimination. Diabetes-free survivals in the experimental groups were assessed by Kaplan–Meier analysis and comparisons between groups were calculated using the

log-rank test. From groups B1, B2 and C2, the three mice that did not deliver a litter were excluded from the analyses. Multivariate analysis of diabetes outcome was performed using the Cox proportional hazards model, which included the covariates mating group and insulin autoantibody www.selleckchem.com/products/Everolimus(RAD001).html titre at the time of mating. Comparisons of insulin autoantibody titres between group A1 and C1 were made using Student’s t-test. Two-tailed P-values of < 0·05 were considered significant. For all statistical methods, PASW statistics version 18 (SPSS, Chicago, IL, USA) was used. Mating at age 10 weeks did not accelerate diabetes, but resulted in a significant delay of diabetes development in the NOD dams (unmated females, 81% diabetes by age 28 weeks, mated females, 60% by age 28 weeks; P = 0·04; Fig. 1a). Differences were observed between mating partners. Mating at 10 weeks with NOD males had no effect on diabetes incidence (71%

by age 28 weeks, P = 0·38), whereas mating with MHC haploidentical CByB6F1/J male mice had the strongest ROS1 effect on diabetes development (38% by age 28 weeks, P = 0·01 versus unmated NOD females; P = 0·08 versus NOD male mated females). Mating with fully MHC mismatched C57BL/6J males did not delay diabetes significantly (73% by age 28 weeks, P = 0·22 versus unmated females). Mating at age 13 weeks did not affect diabetes development significantly in NOD females (unmated females, 94% diabetes by age 28 weeks, mated females, 72% by age 28 weeks; P = 0·22; Fig. 1c) although, again, diabetes development was lowest in females mated with CByB6F1/J male mice (64% by age 28 weeks, P = 0·13).